By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Denali Therapeutics Inc. 

151 Oyster Point Boulevard

South San Francisco  California  94080  U.S.A.
Phone: n/a Fax: n/a


Denali Therapeutics Inc. is a privately held biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Located in South San Francisco, Denali was founded by Drs. Marc Tessier-Lavigne, Ryan Watts, Alex Schuth and investors who share the vision that recent scientific insights in genetics, biology and translational medicine offer an unprecedented opportunity to discover and develop effective medicines for neurodegenerative disease. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include ARCH Venture Partners, F-Prime Biosciences, Flagship Ventures and the Alaska Permanent Fund.




Founder and CEO: Ryan Watts

Founder and COO: Alexander Schuth

Founder: Marc Tessier-Lavigne

CMO: Carole Ho

CFO: Steve Krognes


Please click here for Denali job opportunities.

Key Statistics

Ownership: Private

Web Site: Denali


Company News
The Next Generation: Top 20 Life Science Startups to Watch in 2017 1/3/2017 3:19:44 PM
What You Need to Know About Denali 1/3/2017 3:02:52 PM
f-Star Announces Collaborative Agreement With Denali For The Development Of A Multispecific Antibody Platform To Deliver Therapeutics Across The Blood-Brain Barrier 8/25/2016 9:35:58 AM
Led by Former Genentech (RHHBY) Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships 8/25/2016 6:21:26 AM
Nine Bay Area Biotechs Vie to be the “Next Genentech (RHHBY)” 5/24/2016 6:33:42 AM
Inside the $50 Billion Biotech Sugar Daddy that Invested in Startups Like Denali, Juno (JUNO) 3/3/2016 6:12:41 AM
Denali, Helmed by Former Genentech (RHHBY) Execs, Takes Space in South San Francisco Site 1/18/2016 6:31:47 AM
Denali Appoints Steve E. Krognes As Chief Financial Officer 9/8/2015 9:26:47 AM
Denali Appoints Carole Ho, M.D., As Chief Medical Officer And Head Of Development 7/22/2015 8:04:16 AM
Pfizer (PFE) Board Member Jumps Ship to $217 Million Startup Denali 5/21/2015 9:19:45 AM